Drug interactions between Miradon and Q-Sorb Co Q-10
| Results for the following 2 drugs: |
|---|
| Miradon (anisindione) |
| Q-Sorb Co Q-10 (ubiquinone) |
Interactions between your selected drugs
anisindione ↔ ubiquinone
Applies to:Miradon (anisindione) and Q-Sorb Co Q-10 (ubiquinone)
GENERALLY AVOID: Coadministration with coenzyme Q10 (also known as ubiquinone or ubidecarenone) may reduce the hypoprothrombinemic effect of warfarin and other oral anticoagulants. The exact mechanism of interaction is unknown, although coenzyme Q10 is structurally related to menaquinone (vitamin K2) and may have procoagulant effects. There have been reports of decreased warfarin response in patients using coenzyme Q10 and a return to normal anticoagulation following its discontinuation. In contrast, a study consisting of 24 patients stabilized on warfarin for at least several months found no significant effect of coenzyme Q10 on INR or warfarin dosage compared to placebo, and no thromboembolic events were observed in the study. However, it is important to recognize that pharmacologic effects of herbal products may be highly variable due to inconsistencies in formulation and potency of commercial preparations.
MANAGEMENT: In general, patients should consult a healthcare provider before taking any herbal or alternative medicine. Given the potential for interaction and the narrow therapeutic index of oral anticoagulants, these drugs should preferably not be used with coenzyme Q10. If they are given together, the INR must be checked frequently and anticoagulant dosage adjusted accordingly, particularly following initiation, discontinuation or change of dosage of coenzyme Q10 in patients who are stabilized on their anticoagulant regimen.
See also...
Drug Interaction Classification
The classifications below are a guideline only. The relevance of a particular drug interaction to a specific patient is difficult to determine using this tool alone given the large number of variables that may apply.
| Major | Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. |
| Moderate | Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. |
| Minor | Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. |
Do not stop taking any medications without consulting your healthcare provider.
Disclaimer: Every effort has been made to ensure that the information provided by Multum is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. Multum's drug information does not endorse drugs, diagnose patients, or recommend therapy. Multum's drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2012 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
